Abstract 10627: Benefits of Icosapent Ethyl in Patients with Prior Peripheral Artery Disease: REDUCE-IT PAD

Deepak L. Bhatt,Philippe Gabriel Steg,Michael I. Miller,Eliot A. Brinton,Terry A. Jacobson,Jean-Claude Tardif,Steven B. Ketchum,Rebecca Juliano,Lisa Jiao,Christina Copland,Ralph T. Doyle,Christie M. Ballantyne

Abstract 10627: Benefits of Icosapent Ethyl in Patients with Prior Peripheral Artery Disease: REDUCE-IT PAD

2021

Deepak L. Bhatt
Philippe Gabriel Steg
Michael I. Miller
Eliot A. Brinton
Terry A. Jacobson
Jean-Claude Tardif
Steven B. Ketchum
Rebecca Juliano
Lisa Jiao
Christina Copland
Ralph T. Doyle
Christie M. Ballantyne

Introduction: REDUCE-IT found significant benefit in 8179 statin-treated patients randomized to icosapent ethyl (IPE). Whether that benefit extends to patients with peripheral artery disease (PAD) ...

Keywords:

Cardiology
Disease
arterial disease
Internal medicine
Peripheral artery disease (PAD)
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations